This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bird, I. M. Articles by Rainey, W. E. Search for Related Content PubMed PubMed Citation Articles by Bird, I. M. Articles by Rainey, W. E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL POTASSIUM

(Hypertension. 1995;25:1129-1134.)
© 1995 American Heart Association, Inc.

Articles

Potassium Negatively Regulates Angiotensin II Type 1 Receptor Expression in Human Adrenocortical H295R Cells

Ian M. Bird; R. Ann Word; Colin Clyne; J. Ian Mason; William E. Rainey

From the Departments of Obstetrics and Gynecology, Biochemistry, and Physiology and The Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, and the Departments of Obstetrics and Gynecology, Meriter Hospital, University of Wisconsin, Madison (I.M.B.).

Abstract We have previously shown that the human adrenocortical H295R cell line expresses the type 1 angiotensin II receptor (AT₁-R) and that expression of this receptor is downregulated at the level of mRNA by forskolin or dibutyryl-cAMP as well as by angiotensin II (Ang II). In this study we examine the effects of K⁺ on both AT₁-R mRNA and receptors, as monitored through ¹²⁵I–Ang II binding in the presence of PD 123319. After treatment with a maximal stimulatory steroidogenic dose of K⁺ (14 mmol/L), H295R cells showed an increase in cytosolic free Ca²⁺ from 113 to 212 nmol/L. Unlike the effects of Ang II, this increase could be abolished by pretreatment with the Ca²⁺ channel antagonist nifedipine (1 µmol/L). AT₁-R mRNA levels also fell in response to elevated extracellular K⁺ in a dose-dependent (K_d, 9 mmol/L; maximal fall in message at 12 mmol/L) and time-dependent (maximum 50% at 12 hours) manner. The change in AT₁-R mRNA level was less rapid than that in response to activation of phosphoinositidase C by Ang II or adenylyl cyclase by forskolin or by dibutyryl-cAMP. Unlike the action of Ang II but similar to the action of forskolin or dibutyryl-cAMP, the action of K⁺ was sustained. Changes in mRNA level in response to treatment with K⁺, Ang II, or dibutyryl-cAMP were also paralleled by changes in ¹²⁵I–Ang II binding in each case. The mechanism of action of K⁺ on AT₁-R mRNA also appears to be mediated through the opening of voltage-sensitive channels on the plasma membrane because the drop in AT₁-R mRNA was similarly abolished by the Ca²⁺ channel blocker nifedipine. In conclusion, our findings show that AT₁-R mRNA levels can be controlled through a Ca²⁺-dependent signaling pathway, as well as through phosphoinositidase C or adenylyl cyclase signaling pathways, and that these changes in mRNA level underlie a corresponding change in receptor protein at the cell surface.

Key Words: angiotensin II • receptor • potassium • adrenal • human • calcium

This article has been cited by other articles:

				B. Peters, P. Teubner, S. Clausmeyer, T. Puschner, C. Maser-Gluth, H.-J. Wrede, B. Kranzlin, and J. Peters StAR expression and the long-term aldosterone response to high-potassium diet in Wistar-Kyoto and spontaneously hypertensive rats Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E16 - E23. [Abstract] [Full Text] [PDF]

				D. G. Romero, M. W. Plonczynski, E. P. Gomez-Sanchez, L. L. Yanes, and C. E. Gomez-Sanchez RGS2 Is Regulated by Angiotensin II and Functions as a Negative Feedback of Aldosterone Production in H295R Human Adrenocortical Cells Endocrinology, August 1, 2006; 147(8): 3889 - 3897. [Abstract] [Full Text] [PDF]

				A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF]

				G. Nickenig and D. G. Harrison The AT1-Type Angiotensin Receptor in Oxidative Stress and Atherogenesis: Part II: AT1 Receptor Regulation Circulation, January 29, 2002; 105(4): 530 - 536. [Full Text] [PDF]

				B. J. Clark and R. Combs Angiotensin II and Cyclic Adenosine 3',5'-Monophosphate Induce Human Steroidogenic Acute Regulatory Protein Transcription through a Common Steroidogenic Factor-1 Element Endocrinology, October 1, 1999; 140(10): 4390 - 4398. [Abstract] [Full Text]

				I. M. Bird, D. S. Millican, and R. R. Magness Specific Pregnancy-Induced Angiotensin II Type-1 Receptor Expression in Ovine Uterine Artery Does Not Involve Formation of Alternate Splice Variants or Alternate Promoter Usage Biol Reprod, August 1, 1998; 59(2): 219 - 224. [Abstract] [Full Text]

				G. P. Rossi, G. Albertin, S. Bova, A. S. Belloni, F. Fallo, U. Pagotto, L. Trevisi, G. Palu, A. C. Pessina, and G. G. Nussdorfer Autocrine-Paracrine Role of Endothelin-1 in the Regulation of Aldosterone Synthase Expression and Intracellular Ca2+ in Human Adrenocortical Carcinoma NCI-H295 Cells Endocrinology, October 1, 1997; 138(10): 4421 - 4426. [Abstract] [Full Text] [PDF]

				C. Schmid, H. Castrop, J. Reitbauer, R. Della Bruna, and A. Kurtz Dietary Salt Intake Modulates Angiotensin II Type 1 Receptor Gene Expression Hypertension, April 1, 1997; 29(4): 923 - 929. [Abstract] [Full Text]

				I. M. Bird, J. Zheng, J. M. Cale, and R. R. Magness Pregnancy Induces an Increase in Angiotensin II Type-1 Receptor Expression in Uterine But Not Systemic Artery Endothelium Endocrinology, January 1, 1997; 138(1): 490 - 498. [Abstract] [Full Text] [PDF]